Biology:Phosphogluconate dehydrogenase (decarboxylating)
| phosphogluconate dehydrogenase (decarboxylating) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Phosphogluconate dehydrogenase dimer, Sheep | |||||||||
| Identifiers | |||||||||
| EC number | 1.1.1.44 | ||||||||
| CAS number | 9073-95-4 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| Gene Ontology | AmiGO / QuickGO | ||||||||
| |||||||||
In enzymology, a phosphogluconate dehydrogenase (decarboxylating) (EC 1.1.1.44) is an enzyme that catalyzes the chemical reaction
- 6-phospho-D-gluconate + NADP+ [math]\displaystyle{ \rightleftharpoons }[/math] D-ribulose 5-phosphate + CO2 + NADPH
Thus, the two substrates of this enzyme are 6-phospho-D-gluconate and NADP+, whereas its 3 products are D-ribulose 5-phosphate, CO2, and NADPH.
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating). Other names in common use include phosphogluconic acid dehydrogenase, 6-phosphogluconic dehydrogenase, 6-phosphogluconic carboxylase, 6-phosphogluconate dehydrogenase (decarboxylating), and 6-phospho-D-gluconate dehydrogenase. This enzyme participates in pentose phosphate pathway. It employs one cofactor, manganese.
Enzyme Structure
The general structure, as well as several critical residues, on 6-phosphogluconate dehydrogenase appear to be well conserved over various species. The enzyme is a dimer, with each subunit containing three domains. The N-terminal coenzyme binding domain contains a Rossmann fold with additional α/β units. The second domain consists of a number of alpha helical structures, and the C-terminal domain consists of a short tail.[1] The tails of the two subunits interact with each other to form a mobile lid on the enzyme's active site.[2]
As of late 2007, 11 structures have been solved for this class of enzymes, with PDB accession codes 1PGJ, 1PGN, 1PGO, 1PGP, 1PGQ, 2IYO, 2IYP, 2IZ0, 2IZ1, 2P4Q, and 2PGD.
Enzyme Mechanism
The conversion of 6-phosphogluconate and NADP to ribulose 5-phosphate, carbon dioxide, and NADPH is believed to follow a sequential mechanism with ordered product release. 6-phosphogluconate is first oxidized to 3-keto-6-phosphogluconate and NADPH is formed and released. Then, the intermediate is decarboxylated, yielding a 1,2-enediol of ribulose 5-phosphate, which tautomerizes to form ribulose 5-phosphate.[3] High levels of NADPH are believed to inhibit the enzyme, while 6-phosphogluconate acts to activate the enzyme.[4]
Biological Function
6-phosphogluconate dehydrogenase is involved in the production of ribulose 5-phosphate, which is used in nucleotide synthesis, and functions in the pentose phosphate pathway as the main generator of cellular NADPH.[5]
Disease Relevance
Since NADPH is required by both thioredoxin reductase and glutathione reductase to reduce oxidized thioredoxin and glutathionine, 6-phosphogluconate dehydrogenase is believed to be involved in protecting cells from oxidative damage.[6] Several studies have linked oxidative stress to diseases such as Alzheimer's disease,[7][8] as well as cancer,[9][10] These studies have found phosphogluconate dehydrogenase activity to be up-regulated, both in tumor cells and in relevant cortical regions of Alzheimer's patient brains,[11] most likely as a compensatory reaction to highly oxidative environments.
Recently, phosphogluconate dehydrogenase has been posited as a potential drug target for African sleeping sickness (trypanosomiasis). The pentose phosphate pathway protects the trypanosomes from oxidative stress via the generation of NADPH and provides carbohydrate intermediates used in nucleotide synthesis.[12] Structural differences between mammalian and trypanosome 6-phosphogluconate dehydrogenase have allowed for the development of selective inhibitors of the enzyme. Phosphorylated carbohydrate substrate and transition state analogues, non-carbohydrate substrate analogues and triphenylmethane-based compounds are currently being explored.[13]
References
- ↑ "Structure of 6-phosphogluconate dehydrogenase refined at 2 Å resolution". Acta Crystallogr. D 51 (3): 290–304. 1995. doi:10.1107/S0907444994012229. PMID 15299295. Bibcode: 1995AcCrD..51..290P. http://journals.iucr.org/d/issues/1995/03/00/he0110/he0110.pdf.
- ↑ "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. 2007. doi:10.1186/1472-6807-7-38. PMID 17570834.
- ↑ "Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from Escherichia coli and Klebsiella pneumoniae: Implications for enzyme mechanism". J. Struct. Biol. 169 (1): 25–35. 2010. doi:10.1016/j.jsb.2009.08.006. PMID 19686854. http://ntur.lib.ntu.edu.tw/bitstream/246246/243529/-1/152.pdf.
- ↑ "6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species". Biochim. Biophys. Acta 1429 (1): 83–92. 1998. doi:10.1016/S0167-4838(98)00222-2. PMID 9920387.
- ↑ "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. 2007. doi:10.1186/1472-6807-7-38. PMID 17570834.
- ↑ "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. 2007. doi:10.1186/1472-6807-7-38. PMID 17570834.
- ↑ Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540.
- ↑ "Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress". J. Neurochem. 46 (4): 1042–1045. 1986. doi:10.1111/j.1471-4159.1986.tb00615.x. PMID 3950618.
- ↑ "Persistent oxidative stress in cancer". FEBS Lett. 358 (1): 1–3. 1995. doi:10.1016/0014-5793(94)01368-B. PMID 7821417.
- ↑ "Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors". J. Comp. Pathol. 102 (2): 191–195. 1990. doi:10.1016/S0021-9975(08)80124-7. PMID 2324341.
- ↑ Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540.
- ↑ "Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis". Bioorg. Med. Chem. 11 (14): 3205–14. 2003. doi:10.1016/S0968-0896(03)00191-3. PMID 12818683.
- ↑ "6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes". Curr. Med. Chem. 11 (19): 2639–50. 2004. doi:10.2174/0929867043364441. PMID 15544466.
- "Direct oxidation of glucose-6-phosphate, 6-phosphogluconate and pentose-5-phosphates by enzymes of animal origin". Biochem. J. 50 (1): 81–95. 1951. doi:10.1042/bj0500081. PMID 14904376.
- Bonsignore A; Horecker BL (1961). "Purification and properties of beta-L-hydroxy acid dehydrogenase II. Isolation of beta-keto-L-gluconic acid, an intermediate in L-xylulose biosynthesis". J. Biol. Chem. 236: 2975–2980.
- Scott DBM; Cohen SS (1953). "The oxidative pathway of carbohydrate metabolism in Escherichia coli. 1. The isolation and properties of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase". Biochem. J. 55 (1): 23–33. doi:10.1042/bj0550023. PMID 13093611.
- Scott DBM; Cohen SS (1957). "The oxidative pathway of carbohydrate metabolism in Escherichia coli. 5. Isolation and identification of ribulose phosphate produced from 6-phosphogluconate by the dehydrogenase of E. coli". Biochem. J. 65 (4): 686–689. doi:10.1042/bj0650686. PMID 13426085.
 |  |
